602 filings
Page 4 of 31
8-K
blf0baezu
27 Aug 21
Departure of Directors or Certain Officers
12:00am
8-K
b2g mc7ts2
5 Aug 21
Arrowhead Pharmaceuticals Reports Fiscal 2021 Third Quarter Results
4:06pm
8-K
z6fov5
22 Jun 21
Arrowhead Pharmaceuticals and Horizon Therapeutics Announce Collaboration to Develop RNAi Therapeutic for Uncontrolled Gout
4:09pm
8-K
exzeb
16 Jun 21
Other Events
4:05pm
S-8
14i7yiyu xi0k3oxico
18 May 21
Registration of securities for employees
4:11pm
8-K
y1fjk86l8azez55ley6
4 May 21
Arrowhead Pharmaceuticals Reports Fiscal 2021 Second Quarter Results
4:05pm
8-K
kz9h9wmu4pox
24 Mar 21
Departure of Directors or Certain Officers
5:15pm
UPLOAD
7frzkcfw
8 Mar 21
Letter from SEC
12:00am
CORRESP
zcqa0 brzpe302383t3
5 Feb 21
Correspondence with SEC
12:00am
8-K
lc5k kqufs4qmdqqxw
4 Feb 21
Arrowhead Pharmaceuticals Reports Fiscal 2021 First Quarter Results
4:05pm
UPLOAD
5g4mg3pp c9h
27 Jan 21
Letter from SEC
12:00am
8-K
e7nssdxn v0g6kh
23 Nov 20
Arrowhead Pharmaceuticals Reports Fiscal 2020 Year End Results
4:05pm
8-K
asgms53 iylca3xs3u0
9 Oct 20
Takeda and Arrowhead Collaborate to Co-Develop and Co-Commercialize ARO-AAT for Alpha-1 Antitrypsin-Associated Liver Disease
5:00pm
8-K
s6hsp7gth187awh5ub
8 Sep 20
Departure of Directors or Certain Officers
7:35am
424B5
4syu8zolzat6mj
5 Aug 20
Prospectus supplement for primary offering
5:14pm